| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | President &COO, Lab Ops | President, Pharma Services
2 companies
Cardoza George is a Chief Financial Officer at SOPH with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2021 | NEO Neogenomics Inc | President, Pharma Services | Sell | 200,337 | $40.35 | $8,082,901.47 | -34.2% | +25.3% | -79.9% | |
| Nov 25, 2020 | NEO Neogenomics Inc | President, Pharma Services | Sale+OE | 130,000 | $45.36 | $5,897,051.46 | -14.9% | - | - | |
| Aug 6, 2020 | NEO Neogenomics Inc | President, Pharma Services | Sale+OE | 82,500 | $39.35 | $3,246,375.00 | -19.0% | - | - | |
| Nov 12, 2019 | NEO Neogenomics Inc | President, Pharma Services | Sale+OE | 19,444 | $23.15 | $450,128.60 | -5.6% | - | - | |
| Nov 7, 2019 | NEO Neogenomics Inc | President, Pharma Services | Sale+OE | 55,556 | $22.82 | $1,267,707.92 | -8.4% | - | - | |
| May 3, 2019 | NEO Neogenomics Inc | President, Pharma Services | Sale+OE | 151,676 | $22.82 | $3,461,246.32 | -33.5% | - | - | |
| Mar 11, 2016 | NEO Neogenomics Inc | Chief Financial Officer | Sale+OE | 32,000 | $6.83 | $218,560.00 | -14.5% | - | - |